<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://pharmaexecnews.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.8.4" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.0.1" --><!-- generated-on="July 29, 2010 8:04 am" --><!-- Debug: Total comment count: 0 --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://pharmaexecnews.com/</loc>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings --><!-- Debug: Priority report of postID 10551: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//milestones-mitigate-risk-biotech-deals/</loc>
		<lastmod>2010-07-23T16:05:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//utah-doctor-sentenced-years-illegal-online-pharmacy/</loc>
		<lastmod>2010-07-23T15:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10540: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fastest-growing-therapeutic-classes-sales/</loc>
		<lastmod>2010-07-23T15:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pipeline-soften-lilly-patent-losses/</loc>
		<lastmod>2010-07-23T15:43:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10532: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//specially-engineered-immune-cells-ward-aids/</loc>
		<lastmod>2010-07-11T14:26:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nigeria-takes-fake-drugs-technology/</loc>
		<lastmod>2010-07-11T14:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//top-10-pharma-ceo-salaries-2009/</loc>
		<lastmod>2010-07-11T13:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10519: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//merck-kgaas-pancreatic-cancer-vaccine-ready-testing/</loc>
		<lastmod>2010-07-11T13:08:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mental-health-growing-concern-gulf-spill/</loc>
		<lastmod>2010-07-11T12:38:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//roche-cedes-power-jobs-genentech/</loc>
		<lastmod>2010-07-11T12:37:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//spin-dna-delivery-enhanced-delivery-method-dna-payloads-cells/</loc>
		<lastmod>2010-07-11T12:37:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biggest-developers-play-biosimilar-game/</loc>
		<lastmod>2010-07-11T12:01:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-recalls-tylenol-overthecounter-drugs/</loc>
		<lastmod>2010-07-11T11:23:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//contract-manufacturing-doubledigit-growth/</loc>
		<lastmod>2010-07-11T11:22:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//importance-human-genome-sequencing-debated-10-years/</loc>
		<lastmod>2010-06-29T00:34:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10461: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//md-governor-touts-booming-biotech-biz-jobs/</loc>
		<lastmod>2010-06-29T00:33:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10459: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioterror-lab-target-infectious-disease-therapies/</loc>
		<lastmod>2010-06-29T00:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10463: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pfizers-litany-pipeline-snafus-analysts-fret/</loc>
		<lastmod>2010-06-29T00:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10467: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//antiviral-stem-cell-squad-dispatched-fight-deadly-hiv/</loc>
		<lastmod>2010-06-29T00:32:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10471: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-grow-lungs-skeletons/</loc>
		<lastmod>2010-06-29T00:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//synthetic-drug-users-forty-million/</loc>
		<lastmod>2010-06-29T00:29:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//synthetic-flu-virus-opens-door-safer-vaccines/</loc>
		<lastmod>2010-06-28T20:18:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-imposes-hurdle-cytori-breast-repair-device/</loc>
		<lastmod>2010-06-28T20:05:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diabetes-goals-sanofi/</loc>
		<lastmod>2010-06-27T23:10:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-create-abnormal-heart-cells/</loc>
		<lastmod>2010-06-16T15:05:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10429: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drinking-coffee-reduce-risk-diabetes/</loc>
		<lastmod>2010-06-16T15:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//frontal-cortex-dysfunction-contribute-compulsive-sexual-behavior/</loc>
		<lastmod>2010-06-16T15:03:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10437: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//reducing-toxicity-lithium/</loc>
		<lastmod>2010-06-16T15:03:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rfid-system-checks-rx-compliance/</loc>
		<lastmod>2010-06-16T14:14:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//forget-needles-please-delivers-drugs-lasers/</loc>
		<lastmod>2010-06-15T15:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genome-sequencing-30-harvard-spinoff-promise/</loc>
		<lastmod>2010-06-15T15:06:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10412: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-medical-devices-diagnostics-segment-receives-significant-regulatory-approvals/</loc>
		<lastmod>2010-06-15T00:19:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10407: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-trifecta-generics-markets-personalization/</loc>
		<lastmod>2010-06-14T23:59:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10402: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//otsuka-arm-sales-reps-1300-ipads/</loc>
		<lastmod>2010-06-10T21:50:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//tetraphase-hauls-45m-antibiotic-work/</loc>
		<lastmod>2010-06-02T15:53:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//china-offers-cheaper-educated-labor/</loc>
		<lastmod>2010-06-02T15:51:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cell-culturing-breakthrough/</loc>
		<lastmod>2010-06-02T15:50:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pathway-cheap-insulin/</loc>
		<lastmod>2010-06-02T15:47:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10388: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-cancer-detection-mammograms-improved/</loc>
		<lastmod>2010-06-02T15:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medical-device-deals-decade/</loc>
		<lastmod>2010-05-29T13:58:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10366: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//clinical-conductor-clinical-trial-management-system-enjoys-record-growth/</loc>
		<lastmod>2010-05-29T13:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10363: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//iphone-app-patients-launched-shire/</loc>
		<lastmod>2010-05-29T13:57:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medtronic-invest-70-million-israeli-heart-firm/</loc>
		<lastmod>2010-05-29T13:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//ge-healthcare-invests-5m-cardiodx/</loc>
		<lastmod>2010-05-17T18:10:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10337: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//generic-drug-potential-treatment-deadly-brain-cancer/</loc>
		<lastmod>2010-05-17T18:09:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10335: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//muscle-stem-cell-movements-documented/</loc>
		<lastmod>2010-05-17T18:08:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//inhalable-measles-vax-holds-promise-diseases/</loc>
		<lastmod>2010-05-17T18:07:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-search-master-controller/</loc>
		<lastmod>2010-05-17T18:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10325: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-backbone-nextgeneration-logic-chips/</loc>
		<lastmod>2010-05-17T18:03:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10332: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-pharma-biotech-reengineering/</loc>
		<lastmod>2010-05-17T18:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10297: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nerve-stem-cells-age/</loc>
		<lastmod>2010-05-10T18:10:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10307: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//global-cro-industry-chinas-growing-appeal/</loc>
		<lastmod>2010-05-10T18:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10301: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genes-identified-variation-human-eye-color/</loc>
		<lastmod>2010-05-10T18:08:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10303: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pain-humans-animals-expressed-facial-expressions/</loc>
		<lastmod>2010-05-10T18:07:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10305: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cell-study-ms-shows-early-promise/</loc>
		<lastmod>2010-05-10T18:06:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10299: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//h1n1-vaccine-cancellations-novartis/</loc>
		<lastmod>2010-05-10T18:06:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10293: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-companies-qualify-1b-cash-grants/</loc>
		<lastmod>2010-05-10T17:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10283: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-childrens-drug-recall-congressional-investigation/</loc>
		<lastmod>2010-05-07T11:12:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10286: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//endometriosis-strong-period-pain-excess-weight-childhood-increases-risk/</loc>
		<lastmod>2010-05-07T11:11:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoscale-probe-insert-medication-cell-wall/</loc>
		<lastmod>2010-05-04T01:05:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10277: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-improve-blood-flow-discarded-veins/</loc>
		<lastmod>2010-05-04T01:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10270: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vitamin-status-quality-life-seniors/</loc>
		<lastmod>2010-04-26T18:20:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10266: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//studying-altered-brain-cells-sheds-light-epilepsy/</loc>
		<lastmod>2010-04-26T18:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10262: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//making-blind-gene-therapy-restores-vision-mice/</loc>
		<lastmod>2010-04-26T17:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10248: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//studies-nutrients-gene-expression-lead-tailored-diets-disease-prevention/</loc>
		<lastmod>2010-04-26T17:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10257: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//electronic-medical-record-technology-aids-marathon-participants/</loc>
		<lastmod>2010-04-26T17:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//forecasting-rates-overweight/</loc>
		<lastmod>2010-04-26T17:05:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10244: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//exposure-nitrogen-dioxide-lowers-vitro-fertilization-success/</loc>
		<lastmod>2010-04-13T19:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10239: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//oral-vaccine-reduce-exacerbations-patients-copd/</loc>
		<lastmod>2010-04-13T19:09:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10235: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//roche-deals-2010/</loc>
		<lastmod>2010-04-13T19:04:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10231: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-find-key-gene-promotes-cancer-metastasis/</loc>
		<lastmod>2010-04-13T18:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10227: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-unveils-positive-data-oral-ms-drug-gilenia/</loc>
		<lastmod>2010-04-13T18:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10223: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//work-pressures-nicotine-dependence-study-finds/</loc>
		<lastmod>2010-04-13T18:46:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10210: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medications-faster-harvesting-biomolecules-quickly-reliably/</loc>
		<lastmod>2010-04-11T16:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10208: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//source-recurrent-yeast-infections-autoimmune-syndrome-pinpointed/</loc>
		<lastmod>2010-04-11T16:32:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10206: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//magnetic-attraction-stem-cells-creates-potent-treatment-heart-attack/</loc>
		<lastmod>2010-04-11T16:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//social-influence-plays-role-surging-autism-diagnoses-study-finds/</loc>
		<lastmod>2010-04-11T16:30:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-nanotechnology-magic-bullets-breakthrough-offers-promising-applications-medicine/</loc>
		<lastmod>2010-04-11T16:09:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10179: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jaw-bone-grown-adult-stem-cells/</loc>
		<lastmod>2010-04-01T01:06:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10182: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-reverse-alzheimerslike-memory-loss-fruit-flies/</loc>
		<lastmod>2010-04-01T01:04:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//compulsive-eating-shares-addictive-biochemical-mechanism-cocaine-heroin-abuse-study-shows/</loc>
		<lastmod>2010-04-01T01:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10184: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//judge-invalidates-human-gene-patent/</loc>
		<lastmod>2010-04-01T01:03:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10187: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jaw-bone-grown-adult-stem-cells-2/</loc>
		<lastmod>2010-04-01T01:02:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//federal-court-rejects-vaccinesautism-link/</loc>
		<lastmod>2010-03-21T16:57:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10165: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//jj-rattles-analysts-long-delay-alzheimers-program/</loc>
		<lastmod>2010-03-21T16:56:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10159: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//recommendation-heart-failure-treatment-formulated/</loc>
		<lastmod>2010-03-21T16:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10155: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//chemists-influence-stemcell-development-geometry/</loc>
		<lastmod>2010-03-21T16:41:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//brain-abnormalities-identified-result-prenatal-methamphetamine-exposure/</loc>
		<lastmod>2010-03-21T16:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10147: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//acne-drug-prevents-hiv-breakout/</loc>
		<lastmod>2010-03-21T16:31:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//microbe-detective-seeks-germs/</loc>
		<lastmod>2010-03-21T16:26:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10136: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//feeling-lonely-adds-rate-blood-pressure-increase-people-50-years-older/</loc>
		<lastmod>2010-03-21T16:20:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-model-infant-birth-defect/</loc>
		<lastmod>2010-03-21T16:12:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//unique-genes-surrounding-sequences/</loc>
		<lastmod>2010-03-21T16:07:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10119: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-patent-expirations-2010/</loc>
		<lastmod>2010-03-06T15:11:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10115: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hiring-reps-song-experience/</loc>
		<lastmod>2010-03-06T14:44:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//strategy-produces-promising-advance-cancer-vaccines/</loc>
		<lastmod>2010-03-06T14:10:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//skin-cells-repair-hearts-horizon-biomedical-scientist-brings-stem-cell-research-university/</loc>
		<lastmod>2010-03-06T13:48:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//handheld-device-prevent-migraine/</loc>
		<lastmod>2010-03-06T13:19:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10098: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//grady-hospital-improves-surgical-dept-efficiency/</loc>
		<lastmod>2010-03-06T12:58:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10093: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//clinical-trial-participation-improved-outcomes-childhood-cancer-patients/</loc>
		<lastmod>2010-03-06T12:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10088: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//experts-discuss-challenges-promises-personalized-medicine/</loc>
		<lastmod>2010-03-03T01:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10083: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-ready-leptin-test-type-1-diabetes/</loc>
		<lastmod>2010-03-03T01:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10079: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prize-offer-millions-stem-cell-breakthrough/</loc>
		<lastmod>2010-03-03T00:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-eyes-deals-generics-vaccines/</loc>
		<lastmod>2010-02-26T17:55:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10068: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//effective-prostate-cancer-treatment-discovery/</loc>
		<lastmod>2010-02-26T17:36:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mathematics-good-nights-sleep/</loc>
		<lastmod>2010-02-26T17:11:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10056: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pinch-pain-scorpion-venom-alternative-morphine/</loc>
		<lastmod>2010-02-26T16:51:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10050: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//unpacking-condensins-function-embryonic-stem-cells/</loc>
		<lastmod>2010-02-25T14:55:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//evidence-benefits-high-blood-pressure-drugs-diabetic-eye-disease/</loc>
		<lastmod>2010-02-25T13:45:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10041: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sound-melanoma-ultrasound-doctors-find-cancer-accurately/</loc>
		<lastmod>2010-02-25T13:44:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetic-link-misery-death-discovered-strategy-probes-genetic-haystack/</loc>
		<lastmod>2010-02-25T13:14:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//effectiveness-asthma-relief-inhalers-discovery-opens-avenues-treatment-poorly-controlled-asthma/</loc>
		<lastmod>2010-02-19T16:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10016: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dangers-older-allergy-drugs-underestimated-overlooked/</loc>
		<lastmod>2010-02-19T16:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10010: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//physicists-kill-cancer-nanobubbles/</loc>
		<lastmod>2010-02-19T16:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biologists-image-birth-bloodforming-stem-cells-embryo/</loc>
		<lastmod>2010-02-17T20:06:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 10000: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-map-regions-genome-related-diabetes/</loc>
		<lastmod>2010-02-17T18:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9998: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//free-2010-biotechnology-trends-executive-report/</loc>
		<lastmod>2010-02-04T01:43:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9993: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-show-repair-bone-injuries-rats/</loc>
		<lastmod>2010-02-03T01:29:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9989: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//insect-cells-alternative-swine-flu-vaccines/</loc>
		<lastmod>2010-02-03T01:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9985: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//relation-childrens-brain-cancer-stem-cells/</loc>
		<lastmod>2010-02-03T01:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9981: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rifampicin-promotes-radical-tuberculosis-strain-china/</loc>
		<lastmod>2010-02-03T01:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-vyotrin-cancer/</loc>
		<lastmod>2010-02-01T19:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9972: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hot-cancer-drug-chinese-mushrooms/</loc>
		<lastmod>2010-02-01T19:49:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9967: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-find-weakness-h1n1-evasion-methods/</loc>
		<lastmod>2010-02-01T19:42:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//47-million-doses-flu-vaccine-recalled-astrazeneca/</loc>
		<lastmod>2010-02-01T19:34:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9957: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanotechnology-improves-laboratory-based-heart-cell-growth/</loc>
		<lastmod>2010-02-01T19:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9939: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//novartis-pays-120m-buyout-corthera/</loc>
		<lastmod>2010-01-26T18:23:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9946: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//shionogi-futile-future-obesity-drug/</loc>
		<lastmod>2010-01-26T18:22:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cell-state-change-mechanisms/</loc>
		<lastmod>2010-01-26T16:43:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9926: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-sequencing-faster-cheaper/</loc>
		<lastmod>2010-01-26T16:42:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//xray-imaging-bacterial-cells/</loc>
		<lastmod>2010-01-26T16:40:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9917: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//watch-vitamin/</loc>
		<lastmod>2010-01-18T20:15:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9911: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientists-discover-group-viruses/</loc>
		<lastmod>2010-01-18T16:44:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//risk-severity-h1n1-flu-discovered/</loc>
		<lastmod>2010-01-18T16:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9901: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-prevents-death-cancer-cells/</loc>
		<lastmod>2010-01-18T16:24:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9895: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//researchers-opportunity-annotate-genomes-experimentally/</loc>
		<lastmod>2010-01-18T16:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//advanced-discovered-treating-chronic-infections/</loc>
		<lastmod>2010-01-18T16:02:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-dna-damage-response/</loc>
		<lastmod>2010-01-18T15:52:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9850: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//accessing-drugs-imaging-technique/</loc>
		<lastmod>2009-12-31T18:18:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//morning-espresso-increase-atherosclerosis/</loc>
		<lastmod>2009-12-31T18:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9857: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//ice-cream-researchers-ice-cream-tastier-healthier/</loc>
		<lastmod>2009-12-31T18:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9865: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sheer-mechanical-force-immune-response-diseases/</loc>
		<lastmod>2009-12-31T18:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pfizer-undertakes-major-cutbacks/</loc>
		<lastmod>2009-12-31T18:11:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genetic-revolution-takes-aim-pipeline/</loc>
		<lastmod>2009-12-31T18:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9824: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medicines-snags-rights-pfizer-heart-drug/</loc>
		<lastmod>2009-12-25T16:49:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//astrazeneca-pay-505m-novexel/</loc>
		<lastmod>2009-12-25T16:47:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9807: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//major-hospitals-adopt-medeanalytics-pai-solution-improve-patient-experience/</loc>
		<lastmod>2009-12-25T16:46:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//congress-prepares-deliver-biotechnology/</loc>
		<lastmod>2009-12-25T16:43:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9818: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dealmaking-reaches-fever-pitch-years/</loc>
		<lastmod>2009-12-25T16:40:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9819: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//big-pharma-upends-empires/</loc>
		<lastmod>2009-12-25T16:40:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//oklahomas-largest-health-insurer-redesigns-web-site/</loc>
		<lastmod>2009-12-25T16:39:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9815: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-2009/</loc>
		<lastmod>2009-12-24T21:59:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//generic-drugs-market-trends/</loc>
		<lastmod>2009-12-19T13:19:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-biotech-executives-news-analysis-pharmaexecnewscom/</loc>
		<lastmod>2009-11-24T14:30:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1660: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//schizophrenia-symptoms-caused-traffic-jam-brain/</loc>
		<lastmod>2009-11-24T13:27:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1675: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-supports-cervarix-gardasil/</loc>
		<lastmod>2009-11-12T13:09:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6752: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmareportscom-issues-2010-biotechnology-trends-executive-report/</loc>
		<lastmod>2009-11-12T13:08:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//government-healthcare-proposals-barr-illegal-immigrants-benefits/</loc>
		<lastmod>2009-10-27T17:41:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1658: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cancer-promoted-macrophages/</loc>
		<lastmod>2009-10-02T14:14:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1655: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-map-hiv-virus-deciphered-2/</loc>
		<lastmod>2009-10-02T14:14:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stabilitech-stabilizes-drug-temperatures-budget/</loc>
		<lastmod>2009-10-02T14:13:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1701: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hospitals-cutting-expenses-technology-investments/</loc>
		<lastmod>2009-10-02T14:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1703: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cancer-drug-aflibercept-trials-halted-regeneron-sanofiaventis/</loc>
		<lastmod>2009-10-02T14:13:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1705: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//theravance-astellas-pharma-win-fda-approval-telavancin/</loc>
		<lastmod>2009-10-02T14:12:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1707: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//arizona-telemedicine-program-receives-grant/</loc>
		<lastmod>2009-10-02T14:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1709: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dell-releases-emr-system/</loc>
		<lastmod>2009-10-02T14:11:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1663: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//swine-flu-antivirals-falls/</loc>
		<lastmod>2009-10-01T16:41:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//skin-aging-related-immune-defect/</loc>
		<lastmod>2009-10-01T16:40:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1669: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-urges-public-brush-panic-maneuvers-2/</loc>
		<lastmod>2009-10-01T16:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1671: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//advances-drug-toxicity-microlivers/</loc>
		<lastmod>2009-10-01T16:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1673: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-dynavax-hep-vax-program/</loc>
		<lastmod>2009-10-01T16:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1677: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//merck-significant-advances-oral-ms-drug-race/</loc>
		<lastmod>2009-10-01T16:35:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cells-produce-skin/</loc>
		<lastmod>2009-10-01T16:34:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-risk-blacks-whites-increased-obesity/</loc>
		<lastmod>2009-10-01T16:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sparc-protein-key-link-obesity-diabetes/</loc>
		<lastmod>2009-10-01T16:32:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1681: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//uterine-fibroid-embolization-ufe-safe-nonsurgical-option/</loc>
		<lastmod>2009-10-01T16:31:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 531: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//trends-biochip-market/</loc>
		<lastmod>2009-09-15T19:51:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//alzheimers-prevented-reversed-caffeine/</loc>
		<lastmod>2009-09-15T18:17:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1397: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//health-care-funding-junk-food-sodas-taxed/</loc>
		<lastmod>2009-09-15T18:15:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1395: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//health-care-unaffordable-undeclared-war/</loc>
		<lastmod>2009-09-15T18:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hormone-research-implications-womens-health/</loc>
		<lastmod>2009-09-15T18:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//magnesium-benefits-fully-explored/</loc>
		<lastmod>2009-09-15T18:12:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//metabolic-syndrome-breast-cancer/</loc>
		<lastmod>2009-09-15T18:11:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-preventable-fish-oil-omega3s/</loc>
		<lastmod>2009-09-15T18:09:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1556: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cells-responsible-spread-bladder-cancer-discovered/</loc>
		<lastmod>2009-09-15T18:08:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1552: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//flu-vaccination-preliminary-injunction-issued/</loc>
		<lastmod>2009-09-15T18:07:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1548: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-therapy-trial-successful-boosting-protective-protein-hereditary-lung-disease-patients/</loc>
		<lastmod>2009-09-15T18:05:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1544: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hiv-blocking-gel-women-prevent-aids/</loc>
		<lastmod>2009-09-15T18:04:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1540: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//lung-cancer-prevented-spreading-brain/</loc>
		<lastmod>2009-09-15T18:03:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//phthalates-plastics-pose-danger-unborn-babies/</loc>
		<lastmod>2009-09-15T18:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1530: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-testing-harmful-beneficial/</loc>
		<lastmod>2009-09-15T18:01:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1525: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stem-cell-behavior-regulation-genetic-circuit-discovered/</loc>
		<lastmod>2009-09-15T17:59:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//caffeine-intake-headaches/</loc>
		<lastmod>2009-09-15T17:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pain-spread-prolonged-active-marijuana-ingredients/</loc>
		<lastmod>2009-09-15T17:57:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-urges-public-brush-panic-maneuvers/</loc>
		<lastmod>2009-09-15T17:56:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-map-hiv-virus-deciphered/</loc>
		<lastmod>2009-09-15T17:55:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1413: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//stress-responses-linked-genes/</loc>
		<lastmod>2009-09-15T17:53:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1403: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//indian-biotech-companies-hit-exclusivity-law/</loc>
		<lastmod>2009-09-15T17:52:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1417: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//schistosoma-parasites-debilitating-infections/</loc>
		<lastmod>2009-09-15T17:51:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//heart-cells-automatically-regenerated-1-annually/</loc>
		<lastmod>2009-09-15T17:49:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//swine-flu-vaccine-diseased-african-monkeys/</loc>
		<lastmod>2009-09-15T17:48:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 359: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cytotoxic-drugs/</loc>
		<lastmod>2009-09-15T17:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biochip-technology/</loc>
		<lastmod>2009-09-15T17:45:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-ovarian-cancer-tropism-modified-oncolytic-adenovirus/</loc>
		<lastmod>2009-09-15T17:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-tumors-ingn-007-vrx007-ingn-009-vrx009/</loc>
		<lastmod>2009-09-15T17:42:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanobiotechnology/</loc>
		<lastmod>2009-09-15T17:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-concept-bioburden/</loc>
		<lastmod>2009-09-15T17:40:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 545: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//francisella-tularensis-bioweapon/</loc>
		<lastmod>2009-09-15T17:38:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioinformatics-analysis-market-developments/</loc>
		<lastmod>2009-09-15T17:37:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 550: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//proteomics/</loc>
		<lastmod>2009-09-15T17:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biochips-robotics-engineering/</loc>
		<lastmod>2009-09-15T17:35:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//accessory-signaling-molecules/</loc>
		<lastmod>2009-09-15T17:33:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 521: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-high-grade-astrocytomas-g207-viral-vector/</loc>
		<lastmod>2009-09-15T17:31:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1379: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vitamin-deficiency-instant-solution-healthcare-reform/</loc>
		<lastmod>2009-09-15T17:29:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 504: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//symptoms-lymphoma/</loc>
		<lastmod>2009-09-09T21:54:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//eu-crackdown-pharma-industry/</loc>
		<lastmod>2009-09-09T21:50:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//proponents-threaten-withdraw-biologics-bill-support/</loc>
		<lastmod>2009-09-09T21:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://pharmaexecnews.com/sitemap/</loc>
		<lastmod>2009-09-09T11:53:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://pharmaexecnews.com/research-reports/</loc>
		<lastmod>2009-09-09T11:51:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://pharmaexecnews.com/submit-an-article/</loc>
		<lastmod>2009-08-19T18:40:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 1401: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//white-house-assures-drug-makers-drug-cost-deal/</loc>
		<lastmod>2009-08-12T21:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1405: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//viral-pandemics-history-412-bc-today/</loc>
		<lastmod>2009-08-12T21:33:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1407: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//type-2-diabetes-prevent/</loc>
		<lastmod>2009-08-12T21:32:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1409: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//telaprevir-launch-approaches-vertex-profits/</loc>
		<lastmod>2009-08-12T21:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1411: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//swine-flu-mass-vaccination-program/</loc>
		<lastmod>2009-08-12T21:31:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1415: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//sex-chromosome-males-losing-genes-rapid-evolution/</loc>
		<lastmod>2009-08-12T21:29:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1419: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prescription-drug-benefit-program-flops/</loc>
		<lastmod>2009-08-12T21:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 537: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-genomics/</loc>
		<lastmod>2009-08-06T15:34:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1370: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-funding-scrutiny/</loc>
		<lastmod>2009-08-01T12:01:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-stocks-booming/</loc>
		<lastmod>2009-08-01T12:01:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 533: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-bioinformatics/</loc>
		<lastmod>2009-07-30T11:38:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 535: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-cloning-technology/</loc>
		<lastmod>2009-07-30T11:37:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 511: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//myriad-marburg-virus/</loc>
		<lastmod>2009-07-30T11:37:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 543: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanobiotechnology-diagnostics-therapeutics-medical-devices/</loc>
		<lastmod>2009-07-28T19:00:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology/</loc>
		<lastmod>2009-07-28T18:54:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 515: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//transductional-transcriptional-targeting-adenoviruses/</loc>
		<lastmod>2009-07-28T18:53:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1300: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-companies-free-swine-flu-immunization-lawsuits/</loc>
		<lastmod>2009-07-28T17:27:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 539: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-pharmacogenetics/</loc>
		<lastmod>2009-07-24T23:24:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//reality-antidepressants/</loc>
		<lastmod>2009-07-24T23:17:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1291: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biologics-give-rise-exclusivity-debate/</loc>
		<lastmod>2009-07-24T23:02:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//america-ready-obama-health-plan/</loc>
		<lastmod>2009-07-23T23:16:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 552: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//structural-genomics/</loc>
		<lastmod>2009-07-17T16:47:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1265: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-enhanced-crops-omega3-fatty-acids/</loc>
		<lastmod>2009-07-17T16:30:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-drugs-year-protection/</loc>
		<lastmod>2009-07-14T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1209: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//congress-reform-healthcare/</loc>
		<lastmod>2009-07-13T17:35:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1226: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-drug-copies-held-senate-plan/</loc>
		<lastmod>2009-07-12T04:14:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//drugmakers-reduce-medication-costs-elderly/</loc>
		<lastmod>2009-07-12T04:12:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1171: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//uk-government-support-industrial-biotechnology-sector/</loc>
		<lastmod>2009-06-30T22:55:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1169: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharmaceutical-industry-reduce-drug-costs/</loc>
		<lastmod>2009-06-30T22:54:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1133: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanoparticles-replace-chemotherapy/</loc>
		<lastmod>2009-06-30T22:49:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1141: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//wyeth-pharmaceuticals-loses-court-battle-tune-67-million/</loc>
		<lastmod>2009-06-30T22:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1137: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//seroquel-zyprexa-geodon-treat-children/</loc>
		<lastmod>2009-06-30T22:46:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fda-regulates-tobacco-war-smoking/</loc>
		<lastmod>2009-06-30T22:44:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 518: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//treating-attention-deficit-disorder/</loc>
		<lastmod>2009-06-19T20:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//north-carolina-grants-finance-develop-nanobiotechnology/</loc>
		<lastmod>2009-06-19T20:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vitamin-raise-brain-power/</loc>
		<lastmod>2009-06-19T20:19:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1073: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//climatebased-biotechnology-model-dengue-outbreaks/</loc>
		<lastmod>2009-06-19T20:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//competing-biosimilars-proposed-legislation/</loc>
		<lastmod>2009-06-19T20:14:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1067: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//australian-biotech-industry-receives-boost-budget/</loc>
		<lastmod>2009-06-19T20:12:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1071: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pharma-companies-receive-seed-strains-swine-flu-vaccine/</loc>
		<lastmod>2009-06-19T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//small-business-innovation-research-program-tool-biotech-stalled-congress/</loc>
		<lastmod>2009-06-17T22:20:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 352: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioarrays/</loc>
		<lastmod>2009-06-05T19:41:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1052: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//diversity-biotechnology-boost-virginia-state/</loc>
		<lastmod>2009-06-05T19:39:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cdc-swine-flu-threat/</loc>
		<lastmod>2009-06-05T19:37:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//conventional-modern-approaches-constructing-biochip-systems/</loc>
		<lastmod>2009-06-04T16:34:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//determine-stage-lymphoma/</loc>
		<lastmod>2009-06-04T16:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//emergence-plasma-donation/</loc>
		<lastmod>2009-06-04T16:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//esensor-dna-diagnostics/</loc>
		<lastmod>2009-06-04T16:32:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 392: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//basic-information-prostate-cancer/</loc>
		<lastmod>2009-06-04T16:31:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//facts-hodgkins-lymphoma/</loc>
		<lastmod>2009-06-04T16:31:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 396: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//failure-treatment-lymphoma/</loc>
		<lastmod>2009-06-04T16:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 398: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//febit-holding-introduces-geniomrt-analyzer/</loc>
		<lastmod>2009-06-04T16:27:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 400: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//fluid-technology/</loc>
		<lastmod>2009-06-04T16:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 402: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//focus-electrophoresis/</loc>
		<lastmod>2009-06-04T16:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 404: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//future-market-perspectives-nanobiotechnology/</loc>
		<lastmod>2009-06-04T16:25:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 406: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-expression-chip/</loc>
		<lastmod>2009-06-04T16:24:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 408: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genomic-revolution/</loc>
		<lastmod>2009-06-04T16:23:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//groups-viral-vectors/</loc>
		<lastmod>2009-06-04T16:23:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 412: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//avoid-breast-cancer/</loc>
		<lastmod>2009-06-04T16:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 414: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//deal-depression/</loc>
		<lastmod>2009-06-04T16:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hybridization/</loc>
		<lastmod>2009-06-04T16:21:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//implications-human-genome-project/</loc>
		<lastmod>2009-06-04T16:20:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//importance-bacteriophages/</loc>
		<lastmod>2009-06-04T16:19:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//importance-oncolytic-viruses/</loc>
		<lastmod>2009-06-04T16:19:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//impotency-prostate-cancer-patients/</loc>
		<lastmod>2009-06-04T16:18:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 144: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//chemotherapy-cytotoxic-drugs-cancer-treatment/</loc>
		<lastmod>2009-06-04T16:18:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 202: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//overturning-restrictive-stem-cell-policies-bring-significant-scientific-potential-human-embryonic-stem-cell-research/</loc>
		<lastmod>2009-06-04T16:16:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 426: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//laboratoryonabead-technology/</loc>
		<lastmod>2009-06-04T16:14:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 428: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//learning-breast-cancer/</loc>
		<lastmod>2009-06-04T16:13:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 430: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biopharmaceuticals/</loc>
		<lastmod>2009-06-04T16:12:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cerebral-palsy/</loc>
		<lastmod>2009-06-04T16:12:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//inflammatory-diseases/</loc>
		<lastmod>2009-06-04T16:11:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 436: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genome-adenovirus/</loc>
		<lastmod>2009-06-04T16:11:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 438: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//herpesvirus/</loc>
		<lastmod>2009-06-04T16:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 441: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//reovirus/</loc>
		<lastmod>2009-06-04T16:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 443: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//mapping-chinese-genome/</loc>
		<lastmod>2009-06-04T16:09:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 445: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//microarrays-diagnostics/</loc>
		<lastmod>2009-06-04T16:08:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//modern-insulin-delivery-devices/</loc>
		<lastmod>2009-06-04T16:08:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 449: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//myocardial-infarction/</loc>
		<lastmod>2009-06-04T16:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//offshoring-pharmaceutical-sector/</loc>
		<lastmod>2009-06-04T16:07:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 453: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//outsourcing-pharmaceutical-industry/</loc>
		<lastmod>2009-06-04T16:06:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//patents-intellectual-property-rights-biopharmaceutical-industry/</loc>
		<lastmod>2009-06-04T16:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 457: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pathology-epsteinbarr-virus/</loc>
		<lastmod>2009-06-04T16:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 460: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pegylation-chemistry-mechanisms/</loc>
		<lastmod>2009-06-04T16:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//plaque-rupture-thrombus-formation/</loc>
		<lastmod>2009-06-04T16:04:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 464: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//potential-health-effects-cytotoxic-drugs-waste/</loc>
		<lastmod>2009-06-04T16:03:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 466: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//potential-iceminus-bacteria/</loc>
		<lastmod>2009-06-04T16:01:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 468: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prescription-drug-information/</loc>
		<lastmod>2009-06-04T16:00:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 470: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//processes-involved-proteomics/</loc>
		<lastmod>2009-06-04T16:00:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-diet/</loc>
		<lastmod>2009-06-04T15:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 475: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-chip-technology/</loc>
		<lastmod>2009-06-04T15:59:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 478: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//protein-structure-initiative/</loc>
		<lastmod>2009-06-04T15:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 480: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pulmonary-malignant-granular-cell-tumour/</loc>
		<lastmod>2009-06-04T15:58:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 482: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//research-nanobiotechnology/</loc>
		<lastmod>2009-06-04T15:56:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 484: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//rise-indian-pharmaceutical-industry/</loc>
		<lastmod>2009-06-04T15:55:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 486: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-albumin/</loc>
		<lastmod>2009-06-04T15:54:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-genomics-drug-development/</loc>
		<lastmod>2009-06-04T15:53:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 490: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-proteomics-drug-discovery/</loc>
		<lastmod>2009-06-04T15:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//role-technology-drug-development/</loc>
		<lastmod>2009-06-04T15:52:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 494: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//safety-viral-g207-vector/</loc>
		<lastmod>2009-06-04T15:51:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//selecting-optimal-treatment/</loc>
		<lastmod>2009-06-04T15:50:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//strategic-alliances-drug-development/</loc>
		<lastmod>2009-06-04T15:49:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 500: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//studying-recombinant-vesicular-stomatitis-virus-rvsv/</loc>
		<lastmod>2009-06-04T15:48:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//finding-support-groups-prostate-cancer/</loc>
		<lastmod>2009-06-04T15:48:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-cancer/</loc>
		<lastmod>2009-06-04T15:46:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//future-nanobiotechnology/</loc>
		<lastmod>2009-06-04T15:43:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//india-launch-biotech-units-states/</loc>
		<lastmod>2009-06-04T15:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 736: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-industry-organization-demands-economic-stimulus/</loc>
		<lastmod>2009-06-04T15:42:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 48: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//prostate-cancer-treatment/</loc>
		<lastmod>2009-06-04T15:41:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 101: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-capillary-electrophoresis/</loc>
		<lastmod>2009-06-04T15:38:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 769: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//medical-device-safety-act-2009/</loc>
		<lastmod>2009-06-03T15:10:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 893: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//spend-billion-dollars-swine-flu-vaccine/</loc>
		<lastmod>2009-06-03T15:10:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 668: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//buying-drugs-online-harmful-trend/</loc>
		<lastmod>2009-06-03T15:10:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//genentech-receives-blow-fda-warning-cancer-drug/</loc>
		<lastmod>2009-06-03T15:09:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 896: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//scientific-american-rates-competitive-countries-biotech-sector/</loc>
		<lastmod>2009-05-24T13:51:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//understanding-obamas-healthcare-reforms/</loc>
		<lastmod>2009-05-24T12:50:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 851: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//obama-revises-guidelines-federal-funding-embryonic-stem-cell-research/</loc>
		<lastmod>2009-05-24T12:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//york-city-attract-biotech-companies/</loc>
		<lastmod>2009-05-24T12:47:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 870: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//proposed-patent-reform-act-2009/</loc>
		<lastmod>2009-05-23T01:23:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nhs-funding-problems-developing-stem-cells/</loc>
		<lastmod>2009-05-18T20:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//bioinformatics-drug-discovery-development/</loc>
		<lastmod>2009-05-18T20:15:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 791: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cancer-patients-challenge-patenting-gene-ovarian-breast-cancer/</loc>
		<lastmod>2009-05-18T20:11:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//hemophilia-plasma-donation/</loc>
		<lastmod>2009-05-11T12:57:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 689: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//university-wisconsinmilwaukee-research-pharmaceuticals-water/</loc>
		<lastmod>2009-05-11T12:48:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 507: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//debates-improvement-affordable-medicinal-costs-highlights-risks-benefits-brand-exclusivity-patent-laws/</loc>
		<lastmod>2009-05-07T21:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//vaccines-provide-biotechnology-pharmaceutical-industry-unlimited-potential-market-generic-brand-companies-gaining-ground/</loc>
		<lastmod>2009-05-07T21:54:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 660: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-startups-venture-capital/</loc>
		<lastmod>2009-05-07T21:54:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//agri-biotechnology-research-boost/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotech-swine-flu/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 114: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-applications-biochip-technology/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 607: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//canadas-drug-safety-system-favors-pharmaceutical-companies/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 89: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//breast-cancer-surgery/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 601: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//teva-pharmaceuticals-begins-marketing-pfizers-generic-zoloft-brand/</loc>
		<lastmod>2009-05-05T21:20:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 599: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//warfarin-black-box-warning-weigh-drugs-risks-benefits/</loc>
		<lastmod>2009-05-05T21:20:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pcr-relationship-biochip-technology/</loc>
		<lastmod>2009-04-24T11:55:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//acidophilus/</loc>
		<lastmod>2009-04-15T17:35:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 561: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//g20-pharma-stimulus-package/</loc>
		<lastmod>2009-04-13T11:07:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//pegylation-advantages-potential/</loc>
		<lastmod>2009-04-10T20:23:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//artificial-intelligence-biochips-robotics-engineering/</loc>
		<lastmod>2009-04-02T00:21:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 285: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//nanotechnology-important-biotechnology-field/</loc>
		<lastmod>2009-04-01T23:59:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 84: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-structure-developments-constructing-biochip-systems/</loc>
		<lastmod>2009-04-01T20:41:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 98: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//cellular-adhesion-molecules-selectins/</loc>
		<lastmod>2009-03-17T16:02:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 280: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//biotechnology-development-biochip-industry/</loc>
		<lastmod>2009-03-17T16:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 69: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-therapy-cytolytic-viruses/</loc>
		<lastmod>2009-03-17T15:34:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//gene-therapy-adenovirusmediation/</loc>
		<lastmod>2009-03-17T15:30:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 132: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//dna-analysis-bioarrays/</loc>
		<lastmod>2009-03-16T18:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//barack-obama-and-stem-cell-research/</loc>
		<lastmod>2009-03-16T15:58:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 139: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pharmaexecnews.com//crp-creactive-protein-accessory-signaling-molecule/</loc>
		<lastmod>2009-03-16T14:08:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: End Postings --><!-- Debug: Start Custom Pages --><!-- Debug: End Custom Pages --><!-- Debug: Start additional URLs --><!-- Debug: End additional URLs --></urlset>